Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Medical Countermeasures Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind ChallengeGlobal Biodefense StaffJuly 28, 2025
5 Questions Answered About Chloroquine: An Unproven Drug Against Coronavirus Medical Countermeasures March 25, 2020 …
WUSTL Researchers Investigate Transfusion of Antibodies from Recovered Patients’ as COVID-19 Treatment Medical Countermeasures March 25, 2020 …
FDA Allows Emergency Use of Investigational Convalescent Plasma for Critical COVID-19 Patients Medical Countermeasures March 24, 2020 …
Why Don’t We Have Drugs to Treat COVID-19 and How Long Will It Take to Develop Them? Medical Countermeasures March 21, 2020 …
Ridgeback Biotherapeutics and DRIVE Partner to Develop Clinical Stage Coronavirus Treatment Medical Countermeasures March 19, 2020 …
Lopinavir-Ritonavir Does Not Offer Substantial Benefit in Severe COVID-19 Medical Countermeasures March 18, 2020 …
PharmaJet Receives $9.6 Million Dollar Award to Support Next-Generation Needle-Free Delivery Devices Medical Countermeasures March 17, 2020 …
Novel High-Density Microarray Patch Can Deliver Vaccines Directly to the Skin Medical Countermeasures March 17, 2020 …
Hotel Influenza: Research Heats Up on Universal Flu Vaccines Medical Countermeasures March 17, 2020 …
Regeneron and Sanofi Begin Global Clinical Trial for Use of Sarilumab in Severe COVID-19 Patients Medical Countermeasures March 16, 2020 …
Moderna Announces First Participant Dosed in Phase 1 Study of mRNA Coronavirus Vaccine Medical Countermeasures March 16, 2020 …
CEPI Gets €140 Million Funding Boost From Germany While Expanding Coronavirus Vaccine Search Medical Countermeasures March 13, 2020 …
Using Antibodies from COVID-19 Survivors to Protect Healthcare Workers and Patients Medical Countermeasures March 13, 2020 …
Janssen Scientists Collaborate with BIDMC Virology Lab to Accelerate COVID-19 Vaccine Development Medical Countermeasures March 13, 2020 …
XJTLU Research Indicates No Clinical Benefit for Corticosteroid Treatment of COVID-19 Medical Countermeasures March 13, 2020 …
AbCellera and Eli Lilly to Co-Develop COVID-19 Therapeutic Antibodies Medical Countermeasures March 12, 2020 …
